Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance

被引：1
|
作者：
Burke, Mary [1 ]
Sallman, David A. [2 ]
Denson, Ariel [3 ]
Nelson, Rebecca Jean [3 ]
Chan, Onyee [4 ]
Walker, Alison R. [4 ]
Padron, Eric [4 ]
Xie, Zhuoer [4 ]
Komrokji, Rami S. [4 ]
Lancet, Jeffrey [4 ]
Kuykendall, Andrew T. [4 ]
Tobon, Katherine [3 ]
Jain, Akriti Gupta [1 ]
Wang, Chen [1 ]
Al Ali, Najla H. [1 ,4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia Management
    Goto, Tatsunori
    Numata, Hiroki
    Katsuoka, Yuna
    Uoshima, Nobuhiko
    Hara, Satoru
    Ando, Jun
    Ota, Shuichi
    Yoshimoto, Goichi
    Matsuoka, Akihito
    Hashiba, Hideyuki
    Morita, Tetsuo
    Tsutsui, Atsuko
    Imanaka, Ryota
    ONCOLOGY AND THERAPY, 2025,
  • [22] Association between Body Mass Index and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
    Weiss, Julian J.
    Yates, Samuel J.
    Badar, Talha
    Patel, Anand Ashwin
    Winer, Eric S.
    Litzow, Mark R.
    Cheng, Wei
    Lin, Chenyu
    Shallis, Rory M.
    BLOOD, 2024, 144 : 1489 - 1490
  • [23] A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study
    Smith, B. Douglas
    Lachowiez, Curtis A.
    Ambinder, Alexander Joseph
    Binder, Gary
    Angiolillo, Anne
    Vestin, Assaf
    Paglia, Robert
    Potluri, Ravi
    Papademetriou, Eros
    LeBlanc, Thomas W.
    BLOOD, 2023, 142
  • [24] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Brian A. Jonas
    Daniel A. Pollyea
    Leukemia, 2019, 33 : 2795 - 2804
  • [25] Real World Treatment Patterns and Outcomes of Venetoclax (Ven) and Hypomethylating Agents (HMA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States
    Vachhani, Pankit
    Abbas, Jonathan A.
    Flahavan, Evelyn M.
    Ma, Esprit
    Xu, Tao
    Jin, Huan
    Montez, Melissa
    Huang, Weize
    Gershon, Anda
    Ku, Grace
    Flores, Brannon
    Onishi, Maika
    Bui, Cat N.
    Donnellan, William
    BLOOD, 2021, 138
  • [26] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Jonas, Brian A.
    Pollyea, Daniel A.
    LEUKEMIA, 2019, 33 (12) : 2795 - 2804
  • [27] Validation of the Charlson Comorbidity Index Model in Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax
    Bouligny, Ian
    Murray, Graeme
    Thuy Ho
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    BLOOD, 2023, 142
  • [28] Real-World Treatment Patterns, Resource Utilization, and Cost of Care in Medicare Beneficiaries Newly Diagnosed with Acute Myeloid Leukemia and Treated with Venetoclax-Based Regimens
    Roth, Joshua A.
    D'Amico, Paul G.
    Russell-Smith, Alexander
    Purcell, Simon
    Donckels, Elizabeth
    Cappelleri, Joseph C.
    Ma, Jia
    Petrilla, Allison
    Kagan, Jerry
    Yu, Anthony
    BLOOD, 2024, 144 : 5191 - 5192
  • [29] Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience
    Baba, Yuta
    Hida, Noriko
    Sambe, Takehiko
    Abe, Maasa
    Kabasawa, Nobuyuki
    Sakai, Hirotaka
    Yoshimura, Kiyoshi
    Fukuda, Tetsuya
    ANTICANCER RESEARCH, 2024, 44 (05) : 2003 - 2007
  • [30] A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
    Hu, Rong-Hua
    Su, Li
    Lan, Xiao-Xi
    Chang, Xiao-Li
    Hui, Wu-Han
    Guo, Yi-Xian
    Zhao, Hong
    Zhang, Yue
    Sun, Wan-Ling
    ANTI-CANCER DRUGS, 2023, 34 (03) : 344 - 350
12345